{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:38:27Z","timestamp":1649119107316},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00393-006-0127-3","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T11:19:05Z","timestamp":1165922345000},"page":"41-53","source":"Crossref","is-referenced-by-count":2,"title":["Antiphospholipidsyndrom"],"prefix":"10.1007","volume":"66","author":[{"given":"C.","family":"Specker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,1]]},"reference":[{"key":"127_CR1","unstructured":"Bermas BL, Erkan D, Schur PH (2006\u00a0) Clinical manifestations and diagnosis of antiphospholipid syndrome. UpToDate (14.2)"},{"key":"127_CR2","unstructured":"Bermas BL, Schur PH, Kaplan AA (2006\u00a0b) Prognosis and therapy of the antiphospholipid antibody syndrome. UpToDate (14.2)"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/rheumatology\/37.11.1229","volume":"37","author":"Bertolaccini","year":"1998","unstructured":"Bertolaccini ML, Roch B, Amengual O et al. (1998) Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol 37: 1229\u20131232","journal-title":"Br J Rheumatol"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1177\/096120339800700216","volume":"7","author":"Brey","year":"1998","unstructured":"Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7 [Suppl 2]: S67\u2013S74","journal-title":"Lupus"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46: 1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"127_CR6","doi-asserted-by":"crossref","unstructured":"Erkan D, Yazici Y, Peterson MG et al. (2002) A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 41: 924\u2013929","DOI":"10.1093\/rheumatology\/41.8.924"},{"key":"127_CR7","unstructured":"Feinstein DJ, Rapaport SJ (1972) Acquired inhibitors of blood coagulation. In: Spaet TN (ed) Prog Haemostas Thromb, 1st edn. Grune & Stratton, New York, pp 75\u201395"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2003-40444","volume":"28","author":"Fischer-Betz","year":"2003","unstructured":"Fischer-Betz R, Specker C (2003) Antiphospholipid-Antik\u00f6rper und Schwangerschaft. Akt Rheumatol 28: 131\u2013137","journal-title":"Akt Rheumatol"},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","volume":"117","author":"Ginsburg","year":"1992","unstructured":"Ginsburg KS, Liang MH, Newcomer L et al. (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Inn Med 117: 997\u20131002","journal-title":"Ann Inn Med"},{"key":"127_CR10","first-page":"1560","volume":"31","author":"Giron-Gonzalez","year":"2004","unstructured":"Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C et al. (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31: 1560\u20131567","journal-title":"J Rheumatol"},{"key":"127_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/096120339600500507","volume":"5","author":"Harris","year":"1996","unstructured":"Harris EN, Pierangeli SS (1996) Functional effects of anticardiolipin antibodies. Lupus 5: 372\u2013377","journal-title":"Lupus"},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","volume":"146","author":"Harris","year":"1986","unstructured":"Harris EN, Chan JKH, Asherson RA et al. (1986) Thrombosis, recurrent fetal loss and Thrombocytopenia. Arch Intern Med 146: 2153\u20132156","journal-title":"Arch Intern Med"},{"key":"127_CR13","unstructured":"Harris EN, Hughes GRV, Gharavi AE (1987) The antiphospholipid antibody syndrome. J Rheumatol [Suppl] 13: 210"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","volume":"342","author":"Hughes","year":"1993","unstructured":"Hughes GRV (1993) The antiphospholipid syndrome: ten years on. Lancet 342: 341\u2013344","journal-title":"Lancet"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0046-8177(95)90218-X","volume":"26","author":"Hughson","year":"1995","unstructured":"Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Patol 26: 716\u2013724","journal-title":"Hum Patol"},{"key":"127_CR16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199110103251503","volume":"325","author":"Infante-Rivard","year":"1991","unstructured":"Infante-Rivard C, David M, Gauthier R, Rivard GE (1991) Lupus anticoagulants, anticardiolipin antibodies, and fetal loss \u2013 A case-control study. N Engl J Med 325: 1063\u20131066","journal-title":"N Engl J Med"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","volume":"35","author":"Janardhan","year":"2004","unstructured":"Janardhan V, Wolf PA, Kase CS et al. (2004) Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 35: 736\u2013741","journal-title":"Stroke"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","volume":"295","author":"Lim","year":"2006","unstructured":"Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospholipid antibody syndrome. A systematic review. JAMA 295: 1050\u20131057","journal-title":"JAMA"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1995.tb05324.x","volume":"91","author":"McNally","year":"1995","unstructured":"McNally T, Purdy G, Mackie IJ et al. (1995) The use of anti-\u03b22-glycoprotein I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk for thrombosis. Br J Haematol 91: 471\u2013473","journal-title":"Br J Haematol"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02207667","volume":"10","author":"Meroni","year":"1991","unstructured":"Meroni PL, Rivolta R, Ghidoni P (1991) Histopathological findings in cases of systemic lupus erythematosus-associated antiphospholipid syndrome. Clin Rheumatol 10: 211\u2013214","journal-title":"Clin Rheumatol"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295\u2013306","journal-title":"J Thromb Haemost"},{"key":"127_CR22","first-page":"1589","volume":"22","author":"Mujic","year":"1995","unstructured":"Mujic F, Cuadrado MJ, Lloyd M et al. (1995) Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 22: 1589\u20131592","journal-title":"J Rheumatol"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0037-1613606","volume":"90","author":"Neville","year":"2003","unstructured":"Neville C, Rauch J, Kassis J et al. (2003) Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost 90: 108\u2013115","journal-title":"Thromb Haemost"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","volume":"353","author":"Rosendaal","year":"1999","unstructured":"Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353: 1167\u20131173","journal-title":"Lancet"},{"key":"127_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","volume":"104","author":"Schulman","year":"1998","unstructured":"Schulman S, Svenungsson E, Granqvist S, Duration of Anticoagulation Study Group (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 104: 332\u2013338","journal-title":"Am J Med"},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/096120339800700202","volume":"7","author":"Sheng","year":"1998","unstructured":"Sheng Y, Kandiah DA, Krilis SA (1998) Beta2-glycoprotein I: target antigen for \u201aantiphospholipid\u2018 antibodies. Immunological and molecular aspects. Lupus 7 [Suppl 2]: S5\u2013S9","journal-title":"Lupus"},{"key":"127_CR27","unstructured":"Specker Ch (2002) Das Antiphospholipidsyndrom. Shaker, Aachen"},{"key":"127_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","volume":"96","author":"Vianna","year":"1994","unstructured":"Vianna JL, Khamashta MA, Ordi-Ros J et al. (1994) Comparison of the primary and secondary antiphospholipid syndrome: a european multicenter study of 114 patients. Am J Med 96: 3\u20139","journal-title":"Am J Med"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"127_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-3848(02)00400-0","volume":"108","author":"Wisloff","year":"2002","unstructured":"Wisloff F, Jacobsen EM, Liestol S (2002) Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 108: 263\u2013271","journal-title":"Thromb Res"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0127-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0127-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:29:38Z","timestamp":1559060978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0127-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}